Dr Lalchandani Labs posts profit only because lenders waived ₹61 lacs in debt
Auditors qualified the accounts, flagging NPA classification and unpaid statutory dues since mid-2024. The company holds ₹4.14 cr in cash but won't pay.
— 2 earlier stories on Dr Lalchandani Labs Ltd. →What's new
- FY26 net profit of ₹6.35 lacs rests entirely on a ₹61.08 lacs one-time settlement gain from loan waivers.
- Auditors issued a qualified opinion: accounts are NPA-classified, loans are in default, and statutory dues (PF, TDS) are unpaid since July 2024.
- The company holds ₹4.14 cr cash but has not paid these dues or provided for ₹-- gratuity/leave liabilities.
Why this matters
A qualified audit opinion is a red flag; an NPA classification with defaulted loans is a crisis. The fact that the company reports positive cash yet refuses to pay statutory dues suggests a deliberate cash-preservation strategy at the expense of employees and tax authorities. This is not a company in turnaround. It is a company in distress, managing a cash squeeze by prioritizing survival over compliance.
What we're watching
- Whether lenders initiate formal recovery proceedings given the NPA classification.
- If statutory authorities (PF, TDS) take enforcement action for the long-overdue dues.
- The next quarter's cash position and any further qualification on going-concern.
The full read
Dr Lalchandani Labs' audited FY26 results read like a distress memo. The headline number, a net profit of ₹6.35 lacs, is an accounting fiction. It exists solely because lenders wrote off ₹61.08 lacs in a one-time settlement. The auditors' report tells the real story: the company's accounts are classified as NPA, it has defaulted on loans, and it has not paid statutory dues like Provident Fund or TDS since July 2024. This is while it sits on ₹4.14 crore in cash. The board also swapped the monitoring agency for its rights issue proceeds, replacing Infomerics with Brickwork Ratings, without explanation. For a nano-cap company, the pattern is clear: a cash pile exists, but it is not being used to satisfy employees, the taxman, or creditors. The profit is a mirage; the qualifications are the reality.
Questions answered
- How did the company report a profit when it defaulted on loans?
- A one-time settlement gain of ₹61.08 lacs from lenders waiving parts of its debt allowed Dr Lalchandani to book a net profit of ₹6.35 lacs. Without this one-off, the company would have posted an operational loss.
- What did the auditors say about the company's financial health?
- The auditors issued a qualified opinion, highlighting that the company's accounts are classified as NPA by lenders, loan repayments are in default, and statutory dues including Provident Fund and TDS have been unpaid since July 2024. They also noted that liabilities for employee gratuity and leave encashment have not been provided for.
- The company has ₹4.14 crore in cash. Why haven't the dues been paid?
- The filing does not explain the decision to hold cash rather than pay the long-overdue statutory liabilities. The cash position is stated, but the rationale for the default is absent, deepening the transparency concern.
- What changed with the monitoring agency for the rights issue?
- The board appointed Brickwork Ratings as the new monitoring agency for the proceeds from its rights issue, replacing the previous agency, Infomerics. The filing does not give a reason for the switch.
Story so far
All notes on DLCL →- 3 Jun 2026 · 9:40 PM IST Dr Lalchandani Labs posts profit only because lenders waived ₹61 lacs in debt
- today Lalchandani Labs auditors flag defaults despite cash reserves
- today Dr Lalchandani Labs survives on a one-time settlement. Auditors qualify the accounts.